Dose-dense sequential administration and same day administration of epirubicin and paclitaxel yield similar response rates in women with advanced breast cancer

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)211-213
Number of pages3
JournalEvidence-based Oncology
Volume2
Issue number4
DOIs
Publication statusPublished - 2001

ASJC Scopus subject areas

  • Oncology

Cite this